ALNYLAM PHARMACEUTICALS, INC.
Pharmaceutical Preparations · 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA 02142
官方登记数据
0位关注者
2002成立于
关于 ALNYLAM PHARMACEUTICALS, INC.
Alnylam Pharmaceuticals, Inc. is an American biopharmaceutical company focused on the discovery, development and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts. In 2016, Forbes included the company on its "100 Most Innovative Growth Companies" list.
Source: Wikipedia
行业Pharmaceutical Preparations
总部675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA 02142
成立2002
法律形式C Corporation
状态营业中
专利2398 项专利
Mannan binding lectin serine peptidase 2 (MASP2) IRNA compositions and methods of use thereofUS12709751B2 · 2026
MODIFIED DOUBLE-STRANDED RNA AGENTSUS20260218177A1 · 2026
关键数据
法律信息
| 法定名称 | ALNYLAM PHARMACEUTICALS, INC. |
|---|---|
| 法律形式 | C Corporation |
| SEC CIK | 1178670在 SEC EDGAR 上查看 ↗ |
| EIN | 77-0602661 |
| 行业代码(SIC) | 2834 |
| 注册地址 | 675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA 02142 |
| 状态 | 营业中 |
来源: SEC EDGAR · 更新于 Oct. 15, 2026
联系方式和链接
地点
675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA 02142
这是你的公司吗?
免费认领此页面,即可添加标志、产品、照片和职位,并回复评价。
认领此页面